Page 1

SCI Pharmtech Inc to transfer stake between subsidiaries

Friday, 20 Jun 2014 03:33am EDT

SCI Pharmtech Inc:To transfer shares of a pharmacy company to a wholly owned subsidiary Yushan Holding Universal.Yushan Holding Universal to hold a 100 pct stake in the pharmacy company after transaction.To inject capital $11 million into Yushan Holding.

NanJing Pharmaceutical to dissolve of subsidiary

Tuesday, 10 Jun 2014 08:00pm EDT

NanJing Pharmaceutical Co Ltd:To dissolve of a wholly owned subsidiary in Shanghai, which is engaged in industrial investment and investment consulting business.

Mitsubishi Tanabe Pharma to merge with subsidiary

Thursday, 29 May 2014 03:30am EDT

Mitsubishi Tanabe Pharma Corp:To merge with wholly owned subsidiary Benesis Corporation, which has been engaged in pharmaceutical production and sales business in Osaka, effective Oct. 1.The company will be surviving company and the subsidiary will be dissolved.

Piramal Enterprises Ltd's investment arm to merge private equity with NBFC business-Business Standard

Tuesday, 27 May 2014 06:54am EDT

Piramal Enterprises Ltd:Says the investment arm Piramal Capital has combined its real estate private equity fund management business (Indiareit) and NBFC (Piramal Finance) into an integrated vertical-Business Standard.

Piramal Enterprises Ltd to merge three subsidiaries with parent co - Business Standard

Tuesday, 6 May 2014 10:33am EDT

Piramal Enterprises Ltd:Will merge three of its subsidiaries with the parent company- Business Standard.Under the scheme of amalgamation for merger, subsidiaries such as PHL Capital Private Limited, Piramal Pharmaceutical Development Services Private Limited and Oxygen Bio Research Private Limited will merge with Piramal Enterprises Ltd.

Sun Pharmaceutical Industries Ltd's subsidiary to close down the Detroit plant - Business Standard

Tuesday, 6 May 2014 01:41am EDT

Sun Pharmaceutical Industries Ltd:Has decided to close down the Detroit plant of its US subsidiary, Caraco Pharmaceutical Laboratories Ltd - Business Standard.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.